ストックスクリーナーアプリを入手
4.18
1.88%
-0.08
Codexis Inc (CDXS) 最新ニュース
Specialty Enzymes Market to Expand at 7.5% CAGR, Reaching USD 10.7 Billion by 2032 | SNS Insider - GlobeNewswire Inc.
Codexis announces the approval of equity grants for new employees - MSN
Codexis to Participate in TD Cowen 45th Annual Health Care Conference - The Manila Times
Jordan Seigel - The Globe and Mail
Exclusive: Codexis Unveils Future Roadmap at Major Healthcare Conference - StockTitan
Baillie Gifford & Co. Sells 119,775 Shares of Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Synthetic Biology Market Top Companies StudyBota Biosciences - openPR
abrdn plc Reduces Stake in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Codexis Announces New Employment Inducement Grants - GlobeNewswire
Strategic Talent Investment: Codexis Awards 66.5K Shares in Employee Equity Package - StockTitan
Codexis, Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025 - Nasdaq
Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th - GlobeNewswire
Codexis sees $205,481 stock purchase by Opaleye management By Investing.com - Investing.com South Africa
Codexis sees $205,481 stock purchase by Opaleye management - MSN
Codexis Earnings Alert: Critical Q4 & Full Year Results Coming February 27 - StockTitan
Codexis strengthens board with biotech veteran Arthur Levin - MSN
Codexis strengthens board with biotech veteran Arthur Levin By Investing.com - Investing.com Nigeria
Codexis, Inc. Appoints Dr. Arthur Levin to Strategic Advisory Board to Enhance Oligonucleotide Expertise - Nasdaq
Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board - GlobeNewswire
RNA Drug Development Pioneer Joins Codexis: Oligonucleotide Expert Who Created First Approved Antisense Drugs - StockTitan
Codexis (NASDAQ:CDXS) investors are sitting on a loss of 79% if they invested three years ago - Yahoo Finance
Codexis, Inc. (NASDAQ:CDXS) Sees Large Increase in Short Interest - MarketBeat
Taking a Closer Look At Codexis Inc (CDXS) Following Its Recent Trade - Knox Daily
Can you now get a good deal on Codexis Inc’s shares? - US Post News
Biocatalysis Market is Projected to Increase at a CAGR of 5.2% - openPR
Ratio Revelations: Codexis Inc (CDXS)’s Financial Metrics in the Spotlight - The Dwinnex
Institutional investors in Codexis, Inc. (NASDAQ:CDXS) see US$59m decrease in market cap last week, although long-term gains have benefitted them. - Simply Wall St
5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io
Codexis, Inc. to Host Earnings Call - ACCESS Newswire
Inspire Investing LLC Takes $405,000 Position in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Codexis, Inc. (NASDAQ:CDXS) Shares Sold by Assenagon Asset Management S.A. - Defense World
Assenagon Asset Management S.A. Has $1.37 Million Stock Position in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Cantor Fitzgerald Forecasts Codexis FY2025 Earnings - Defense World
Cantor Fitzgerald Comments on Codexis FY2025 Earnings - MarketBeat
Codexis expands board with new director Christos Richards - MSN
Codexis, Inc. (NASDAQ:CDXS) Sees Significant Increase in Short Interest - MarketBeat
Codexis expands board with new director Christos Richards By Investing.com - Investing.com Australia
Tallon Kerry Patrick Purchases New Position in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Barclays PLC Purchases 70,255 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Barclays PLC Has $640,000 Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat
Codexis Appoints Christos Richards to Board of Directors - Taiwan News
Codexis appoints new independent director By Investing.com - Investing.com Australia
Codexis, Inc. Appoints Christos Richards to Board of Directors -January 16, 2025 at 04:05 pm EST - Marketscreener.com
Codexis appoints new independent director - Investing.com India
Codexis Strengthens Board with Life Sciences Veteran Christos Richards, Expert in 450+ Executive Placements - StockTitan
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):